BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 26896572)

  • 1. Metabolomics approach to explore the effects of Kai-Xin-San on Alzheimer's disease using UPLC/ESI-Q-TOF mass spectrometry.
    Chu H; Zhang A; Han Y; Lu S; Kong L; Han J; Liu Z; Sun H; Wang X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Mar; 1015-1016():50-61. PubMed ID: 26896572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterizing serum metabolic alterations of Alzheimer's disease and intervention of Shengmai-San by ultra-performance liquid chromatography/electrospray ionization quadruple time-of-flight mass spectrometry.
    Lu S; Han Y; Chu H; Kong L; Zhang A; Yan G; Sun H; Wang P; Wang X
    Food Funct; 2017 Apr; 8(4):1660-1671. PubMed ID: 28379235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classic Famous Prescription Kai-Xin-San Ameliorates Alzheimer's Disease via the Wnt/β-Catenin Signaling Pathway.
    Shan X; Lv S; Huang P; Zhang W; Jin C; Liu Y; Li Y; Jia Y; Chu X; Peng C; Zhang C
    Mol Neurobiol; 2024 Apr; 61(4):2297-2312. PubMed ID: 37874481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid discovery of quality-markers from Kaixin San using chinmedomics analysis approach.
    Wang XJ; Zhang AH; Kong L; Yu JB; Gao HL; Liu ZD; Sun H
    Phytomedicine; 2019 Feb; 54():371-381. PubMed ID: 30322673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A UPLC-TOF/MS-based metabolomics study of rattan stems of Schisandra chinensis effects on Alzheimer's disease rats model.
    Yang BY; Tan JY; Liu Y; Liu B; Jin S; Guo HW; Kuang HX
    Biomed Chromatogr; 2018 Feb; 32(2):. PubMed ID: 28664556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput lipidomics analysis to discover lipid biomarkers and profiles as potential targets for evaluating efficacy of Kai-Xin-San against APP/PS1 transgenic mice based on UPLC-Q/TOF-MS.
    Zhang AH; Ma ZM; Kong L; Gao HL; Sun H; Wang XQ; Yu JB; Han Y; Yan GL; Wang XJ
    Biomed Chromatogr; 2020 Feb; 34(2):e4724. PubMed ID: 31755117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The memory enhancement effect of Kai Xin San on cognitive deficit induced by simulated weightlessness in rats.
    Qiong W; Yong-Liang Z; Ying-Hui L; Shan-Guang C; Jiang-Hui G; Yi-Xi C; Ning J; Xin-Min L
    J Ethnopharmacol; 2016 Jul; 187():9-16. PubMed ID: 27103112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Mechanism of Kai Xin San on Alzheimer's Disease Based on Network Pharmacology and Experimental Validation.
    Wang K; Yang R; Chen TT; Qin MR; Wang P; Kong MW
    Chin J Integr Med; 2023 May; 29(5):413-423. PubMed ID: 36474082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ginsenosides attenuate d-galactose- and AlCl
    Zhang Y; Pi Z; Song F; Liu Z
    J Ethnopharmacol; 2016 Dec; 194():188-195. PubMed ID: 27612432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-depressive effects of Kai-Xin-San on lipid metabolism in depressed patients and CUMS rats using metabolomic analysis.
    Zhou X; Wang J; Lu Y; Chen C; Hu Y; Liu P; Dong X
    J Ethnopharmacol; 2020 Apr; 252():112615. PubMed ID: 31991203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kai-Xin-San, a standardized traditional Chinese medicine formula, up-regulates the expressions of synaptic proteins on hippocampus of chronic mild stress induced depressive rats and primary cultured rat hippocampal neuron.
    Zhu Y; Duan X; Cheng X; Cheng X; Li X; Zhang L; Liu P; Su S; Duan JA; Dong TT; Tsim KW; Huang F
    J Ethnopharmacol; 2016 Dec; 193():423-432. PubMed ID: 27660009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of multiple constituents in Kai-Xin-San prescription and rat plasma after oral administration by liquid chromatography with quadrupole time-of-flight tandem mass spectrometry.
    Zhang X; Li Q; Lv C; Xu H; Liu X; Sui Z; Bi K
    J Sep Sci; 2015 Jun; 38(12):2068-75. PubMed ID: 25845859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum metabolomics strategy for understanding pharmacological effects of ShenQi pill acting on kidney yang deficiency syndrome.
    Nan Y; Zhou X; Liu Q; Zhang A; Guan Y; Lin S; Kong L; Han Y; Wang X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jul; 1026():217-226. PubMed ID: 26747643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomics study on Fuzi and its processed products using ultra-performance liquid-chromatography/electrospray-ionization synapt high-definition mass spectrometry coupled with pattern recognition analysis.
    Sun H; Ni B; Zhang A; Wang M; Dong H; Wang X
    Analyst; 2012 Jan; 137(1):170-85. PubMed ID: 22030742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomic study of insomnia and intervention effects of Suanzaoren decoction using ultra-performance liquid-chromatography/electrospray-ionization synapt high-definition mass spectrometry.
    Yang B; Zhang A; Sun H; Dong W; Yan G; Li T; Wang X
    J Pharm Biomed Anal; 2012 Jan; 58():113-24. PubMed ID: 22019702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kai Xin San aqueous extract improves Aβ
    Lu C; Shi Z; Sun X; Pan R; Chen S; Li Y; Qu L; Sun L; Dang H; Bu L; Chen L; Liu X
    J Ethnopharmacol; 2017 Apr; 201():73-81. PubMed ID: 27751826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolomics study on the toxicity of aconite root and its processed products using ultraperformance liquid-chromatography/electrospray-ionization synapt high-definition mass spectrometry coupled with pattern recognition approach and ingenuity pathways analysis.
    Wang X; Wang H; Zhang A; Lu X; Sun H; Dong H; Wang P
    J Proteome Res; 2012 Feb; 11(2):1284-301. PubMed ID: 22053844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global identification and determination of the major constituents in Kai-Xin-San by ultra-performance liquid chromatography-quadrupole-Orbitrap mass spectrometry and gas chromatography-mass spectrometry.
    Lin R; Yin J; Wu M; Ding H; Han L; Yang W; Song X; Bie S; Wang C; He Y; Yu H; Li Z
    J Pharm Biomed Anal; 2021 Nov; 206():114385. PubMed ID: 34597841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamic and urinary metabolomics studies on the mechanism of Schisandra polysaccharide in the treatment of Alzheimer's disease.
    Liu Y; Liu Z; Wei M; Hu M; Yue K; Bi R; Zhai S; Pi Z; Song F; Liu Z
    Food Funct; 2019 Jan; 10(1):432-447. PubMed ID: 30623955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UHPLC-QTOF/MS-based metabolomics investigation for the protective mechanism of Danshen in Alzheimer's disease cell model induced by Aβ
    Zhang M; Liu Y; Liu M; Liu B; Li N; Dong X; Hong Z; Chai Y
    Metabolomics; 2019 Jan; 15(2):13. PubMed ID: 30830431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.